ALIMERA SCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.52 USD | 0.00% |
|
+80.98% | +27.78% |
| 06-25 | Maxim Downgrades Alimera Sciences to Hold From Buy | MT |
| 06-25 | Alliance Global Partners Downgrades Alimera Sciences to Neutral From Buy, Adjusts Price Target to $5.50 From $8 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 289M | - | - | - | |||
| 94.74B | ||||||
| 37.28B | ||||||
| 32.68B | ||||||
| 27.72B | ||||||
| 16.19B |
